	Precision Oncology in Lung Cancer Surgery. Hematol Oncol Clin North Am Bou-Samra P, Singhal S. PMID: 42686329 [PubMed - indexed for MEDLINE]
	Assessing Guideline-Directed Care in the New Era of Neoadjuvant Therapy in Early-Stage Resectable Non-small Cell Lung Cancer (NSCLC): A Retrospective Review. Clin Lung Cancer Maity AP, Kjelstrom S, Gu H, Sanborn M, Kalola A, Savior D, Ghaneie A, Dessain SK. PMID: 42685613 [PubMed - as supplied by publisher]
	MTAP loss in non-small-cell lung Cancer and beyond: Therapeutic targeting of the MAT2A-PRMT5 axis. Cancer Treat Rev Arter ZL, Shim JSG, Park C, Waliany S, Lim SM, Soo RA. PMID: 42685449 [PubMed - as supplied by publisher]
	Differential analysis of lung adenocarcinoma and lung squamous cell carcinoma based on serum tumor markers: diagnostic performance and clinical utility. Clinics (Sao Paulo) Chen Z, Chen L, Wu L, Zhang K. PMID: 42685377 [PubMed - as supplied by publisher]
	Pulmonary Nodules. N Engl J Med Callister MEJ, Silvestri GA. PMID: 42685318 [PubMed - indexed for MEDLINE]
	Robotic-assisted versus video-assisted thoracoscopic anatomical lung resection for early-stage non-small cell lung cancer: a systematic review and meta-analysis. J Robot Surg Johow Reichert M, Urnía N, Jofré A, Sanhueza L, Ortega JI, Mordojovich G. PMID: 42684651 [PubMed - indexed for MEDLINE]
	Durvalumab-associated nephrotic syndrome and organizing pneumonia: a case report. CEN Case Rep Nawata T, Shibuya M, Asami-Noyama M, Uesugi N, Sano M. PMID: 42684586 [PubMed - indexed for MEDLINE]
	Epigenetic Profiling for Early Detection and Treatment Response Monitoring in Non-Small Cell Lung Cancer: Protocol for a Prospective Translational Biomarker Study. JMIR Res Protoc Kumar R, Farry SM, Ezegbogu M, Reid G, Rodger EJ, Brockway B, Chatterjee A. PMID: 42684344 [PubMed - indexed for MEDLINE]
	Bifidobacterium animalis subsp. lactis V9 overcomes CYFRA 21-1-linked immunochemotherapy resistance in NSCLC via microbial metabolites. Sci Adv Feng C, Gao G, He Q, Kwok LY, Liu C, Li C, Dong L, Sun Z, Zhang H. PMID: 42685222 [PubMed - indexed for MEDLINE]
	A phase II multi-institutional single arm trial evaluating TG4010 vaccine plus nivolumab in non-small cell lung cancer. Oncoimmunology Wang CX, Luxardi G, Mori H, Maverakis EM, Merleev AA, Marusina AI, Borowsky AD, Parikh M, Riess JW, Moshiri A, Bazhenova L, Gubens M, Koczywas M, Butner JD, Huang J, Kim SK, Vick LV, Sun Y, Canter RJ, Murphy WJ, Daly ME, Kelly K, Monjazeb AM. PMID: 42684015 [PubMed - indexed for MEDLINE]
	The neuro-immune-vascular landscape of lung cancer brain metastasis: insights from organoid models. Front Immunol Li J, Xu M, Wang L, Yu Y. PMID: 42683414 [PubMed - indexed for MEDLINE]
	From description to prediction: a multi-database bibliometric forecast-validation study of lung cancer and tumor-associated macrophages research (2005-2025). Front Immunol Zhang T, Zeng J, Li X, Wang Y, Han X. PMID: 42682714 [PubMed - indexed for MEDLINE]
	Balancing diagnostic approach and oncologic risk in surgically resected lung cancer: propensity-matched analysis of intraoperative versus percutaneous biopsy by tumor location and morphology. Int J Surg Jung Y, Yi E, Hwang SH, Lee S, Chung JH. PMID: 42682368 [PubMed]
	Commentary on: Beneficial outcomes of surgical combination therapy for patients with N3M0 non-small cell lung cancer: a retrospective cohort study. Int J Surg Cao J, Liu C, Ren Y. PMID: 42682359 [PubMed]
	The next frontier of immunotherapy: clinical trial prospects for lung cancer vaccines. Int J Surg Zhu QD, Song C, Zhao CY, Jiang CY, Qiang HB, Yang XM, Lu YB, Xie ZH. PMID: 42682302 [PubMed]
	Effect of Tertiary Lymphoid Structures on Immune Cell Infiltration in the Tumor Microenvironment and Prognosis in Lung Adenocarcinoma. Cancer Med Le S, Fang W, Le Y, Zhang L. PMID: 42681847 [PubMed - indexed for MEDLINE]
	ERRATUM: Impact of TTF-1 Expression on the Prognostic Prediction of Patients with Non-Small Cell Lung Cancer with PD-L1 Expression Levels of 1% to 49%, Treated with Chemotherapy vs. Chemoimmunotherapy: A Multicenter, Retrospective Study. Cancer Res Treat Nishioka N, Hata T, Yamada T, Goto Y, Amano A, Negi Y, Watanabe S, Furuya N, Oba T, Ikoma T, Nakao A, Tanimura K, Taniguchi H, Yoshimura A, Fukui T, Murata D, Kaira K, Shiotsu S, Hibino M, Okada A, Chihara Y, Kawachi H, Kijima T, Takayama K. PMID: 42681797 [PubMed - as supplied by publisher]
	The Advanced Lung Cancer Inflammation Index Is Not Independently Prognostic for Overall Survival in De Novo Metastatic Pancreatic Cancer: A Comparison with Established Inflammation- and Nutrition-based Scores. J Gastrointest Cancer Ayd, Köksoy EB. PMID: 42681259 [PubMed - indexed for MEDLINE]
	Correction: Anti-PDGFRÎ± autoantibody - a novel diagnostic and prognostic marker - may mediate non-small cell lung cancer progression via the PI3K/AKT/NF-ÎºB signaling pathway. Br J Cancer Chen F, Chen Y, Sun W, Ma H, Liang Y, Li Y, Li J, Cao X, Ouyang S, Dai L. PMID: 42680890 [PubMed - as supplied by publisher]
	Patient-reported outcomes with tarlatamab in extensive-stage small cell lung cancer after platinum-based chemotherapy: results from the phase 3 DeLLphi-304 trial. Lung Cancer Mountzios G, Lammers PE, Sun L, Cho BC, Demirci U, Arulananda S, Gumus M, Punekar S, Lugini A, Zhu B, Yu Y, Ciuleanu TE, Ahn MJ, Mazieres J, Schuler M, Blackhall F, Yoshida T, Dirnberger F, Wang J, Huang S, Gauto D, Rudin CM. PMID: 42679738 [PubMed - as supplied by publisher]

Articles 1 - 20 / 161723

Page 1 of 8087



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy